Targeting Alpha-Synuclein: Breakthroughs in the Quest to Halt Parkinson's Progression

Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology, Molecular Neurodegeneration

Biomolecules, Free Full-Text

A Peptide Approach to Reducing alpha-Synuclein in Parkinson's Disease

Frontiers Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough

The Odyssey of Alpha-synuclein and Neuroinflammatory Mediators as Potential Candidates in the Aetiology of Parkinson's Disease

Alpha Synuclein SUMOylation: A Novel Therapeutic Target for Parkinson's Disease

Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson's disease

Unique Protein Structures Could Hold the Key to Parkinson's Disease - Neuroscience News

Pharmaceutics, Free Full-Text

The search for the holy grail: Promising stra